BALCHEM CORP (BCPC) Executive Compensation
BALCHEM CORP (BCPC) is a publicly traded company on the Nasdaq, categorized under SIC 2800 (Chemicals & Allied Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BCPC
CIK: 9326
Exchange: Nasdaq
SIC 2800: Chemicals & Allied Products
Fiscal Year End: 12/31
State: MD
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerThomas Conza
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-09-24 | 2026-09-16 | FORM 3 | 0001140361-26-037570 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0000009326-26-000028 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | 8-K | 0000009326-26-000026 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-24 | 8-K | 0001140361-26-029658 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001140361-26-025971 | View SEC Doc Filr Page |
| 11-K | 2026-06-18 | 2025-12-31 | 11-K | 0000009326-26-000022 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0000009326-26-000018 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0000009326-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002100119-26-000260 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-28 | — | SCHEDULE 13G Filing | 0002100121-26-000135 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001140361-26-017104 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-18 | DEF 14A | 0001140361-26-017099 | View SEC Doc Filr Page |
| 3 | 2026-04-07 | 2026-04-01 | FORM 3 | 0001140361-26-013681 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-000770 | View SEC Doc Filr Page |
| 10-K | 2026-02-20 | 2025-12-31 | 10-K | 0000009326-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-20 | 8-K | 0000009326-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-02-19 | 2026-02-12 | 8-K | 0001140361-26-006184 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005544 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005542 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005536 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005533 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005531 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005520 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005516 | View SEC Doc Filr Page |
| 4 | 2026-02-13 | 2026-02-11 | FORM 4 | 0001140361-26-005512 | View SEC Doc Filr Page |